Amitriptyline for fibromyalgia: Off-label treatment, but non-inferior to approved medication

Int J Rheum Dis. 2023 Apr;26(4):607-608. doi: 10.1111/1756-185X.14618.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Amitriptyline* / adverse effects
  • Fibromyalgia* / diagnosis
  • Fibromyalgia* / drug therapy
  • Humans
  • Off-Label Use

Substances

  • Amitriptyline